197 related articles for article (PubMed ID: 1714341)
41. Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen.
Sharkey RM; Kaltovich FA; Shih LB; Fand I; Govelitz G; Goldenberg DM
Cancer Res; 1988 Jun; 48(11):3270-5. PubMed ID: 3365705
[TBL] [Abstract][Full Text] [Related]
42. Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
Reist CJ; Archer GE; Wikstrand CJ; Bigner DD; Zalutsky MR
Cancer Res; 1997 Apr; 57(8):1510-5. PubMed ID: 9108453
[TBL] [Abstract][Full Text] [Related]
43. Local hyperthermia improves uptake of a chimeric monoclonal antibody in a subcutaneous xenograft model.
Hauck ML; Dewhirst MW; Bigner DD; Zalutsky MR
Clin Cancer Res; 1997 Jan; 3(1):63-70. PubMed ID: 9815539
[TBL] [Abstract][Full Text] [Related]
44. Single-Dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using 131I-labeled multivalent CC49 single-chain fvs.
Goel A; Augustine S; Baranowska-Kortylewicz J; Colcher D; Booth BJ; Pavlinkova G; Tempero M; Batra SK
Clin Cancer Res; 2001 Jan; 7(1):175-84. PubMed ID: 11205906
[TBL] [Abstract][Full Text] [Related]
45. Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.
Reardon DA; Akabani G; Coleman RE; Friedman AH; Friedman HS; Herndon JE; McLendon RE; Pegram CN; Provenzale JM; Quinn JA; Rich JN; Vredenburgh JJ; Desjardins A; Gururangan S; Badruddoja M; Dowell JM; Wong TZ; Zhao XG; Zalutsky MR; Bigner DD
J Clin Oncol; 2006 Jan; 24(1):115-22. PubMed ID: 16382120
[TBL] [Abstract][Full Text] [Related]
46. Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts.
Sharkey RM; Motta-Hennessy C; Pawlyk D; Siegel JA; Goldenberg DM
Cancer Res; 1990 Apr; 50(8):2330-6. PubMed ID: 2180566
[TBL] [Abstract][Full Text] [Related]
47. Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin.
He X; Archer GE; Wikstrand CJ; Morrison SL; Zalutsky MR; Bigner DD; Batra SK
J Neuroimmunol; 1994 Jul; 52(2):127-37. PubMed ID: 7518471
[TBL] [Abstract][Full Text] [Related]
48. Treatment of small-cell lung cancer xenografts with iodine-131-anti-neural cell adhesion molecule monoclonal antibody and evaluation of absorbed dose in tissue.
Hosono M; Endo K; Hosono MN; Kobayashi H; Shirato M; Sakahara H; Ueda R; Konishi J
J Nucl Med; 1994 Feb; 35(2):296-300. PubMed ID: 8295002
[TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies.
Zalutsky MR; Moseley RP; Coakham HB; Coleman RE; Bigner DD
Cancer Res; 1989 May; 49(10):2807-13. PubMed ID: 2469537
[TBL] [Abstract][Full Text] [Related]
50. Preclinical therapy of breast cancer with a radioiodinated humanized anti-EGP-1 monoclonal antibody: advantage of a residualizing iodine radiolabel.
Govindan SV; Stein R; Qu Z; Chen S; Andrews P; Ma H; Hansen HJ; Griffiths GL; Horak ID; Goldenberg DM
Breast Cancer Res Treat; 2004 Mar; 84(2):173-82. PubMed ID: 14999147
[TBL] [Abstract][Full Text] [Related]
51. The localisation of radiolabelled murine monoclonal antibody 81C6 and its Fab fragment in human glioma xenografts in athymic mice.
Colapinto EV; Lee YS; Humphrey PA; Zalutsky MR; Friedman HS; Bullard DE; Bigner DD
Br J Neurosurg; 1988; 2(2):179-91. PubMed ID: 3267302
[TBL] [Abstract][Full Text] [Related]
52. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis.
DeNardo GL; DeNardo SJ; Wessels BW; Kukis DL; Miyao N; Yuan A
Cancer Biother Radiopharm; 2000 Dec; 15(6):547-60. PubMed ID: 11190487
[TBL] [Abstract][Full Text] [Related]
53. Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report.
Bigner DD; Brown M; Coleman RE; Friedman AH; Friedman HS; McLendon RE; Bigner SH; Zhao XG; Wikstrand CJ; Pegram CN
J Neurooncol; 1995; 24(1):109-22. PubMed ID: 8523067
[TBL] [Abstract][Full Text] [Related]
54. [Experimental study for the targeting therapy of mouse lung carcinoma treated by anti-hnRNPB1 monoclonal antibody with 131I].
Chen MY; Li WM; Xu D; Chen WB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):766-9. PubMed ID: 17953353
[TBL] [Abstract][Full Text] [Related]
55. Monoclonal antibody localization in subcutaneous and intracranial human glioma xenografts: paired-label and imaging analysis.
Bourdon MA; Coleman RE; Blasberg RG; Groothuis DR; Bigner DD
Anticancer Res; 1984; 4(3):133-40. PubMed ID: 6465851
[TBL] [Abstract][Full Text] [Related]
56. Radioimmunotherapy of MCF7 breast cancer cell line with 131I-PR81 monoclonal antibody against MUC1: comparison of direct and indirect radioiodination methods.
Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Hasan ZM; Salouti M; Gandomkar M; Sadri K
Hum Antibodies; 2010; 19(1):15-25. PubMed ID: 20555127
[TBL] [Abstract][Full Text] [Related]
57. Specific imaging of human brain tumor xenografts utilizing radiolabelled monoclonal antibodies (MAbs).
Bullard DE; Wikstrand CJ; Humphrey PA; Lee YS; Coleman RE; Zalutsky M; Bigner DD
Nuklearmedizin; 1986 Dec; 25(6):210-5. PubMed ID: 3808960
[TBL] [Abstract][Full Text] [Related]
58. Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization.
Arano Y; Wakisaka K; Ohmomo Y; Uezono T; Mukai T; Motonari H; Shiono H; Sakahara H; Konishi J; Tanaka C
J Med Chem; 1994 Aug; 37(16):2609-18. PubMed ID: 8057303
[TBL] [Abstract][Full Text] [Related]
59. Tissue distribution and radiation dosimetry of astatine-211-labeled chimeric 81C6, an alpha-particle-emitting immunoconjugate.
Zalutsky MR; Stabin MG; Larsen RH; Bigner DD
Nucl Med Biol; 1997 Apr; 24(3):255-61. PubMed ID: 9228660
[TBL] [Abstract][Full Text] [Related]
60. Optimization of radioiodination and biotinylation of monoclonal antibody chimeric BR96: an indirect labeling using N-succinimidyl-3-(tri-n-butylstannyl)benzoate conjugate.
Chen J; Strand SE; Sjögren HO
Cancer Biother Radiopharm; 1996 Jun; 11(3):217-26. PubMed ID: 10851540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
